DSP Credit Risk IDCW Monthly Payout Direct Plan
SIP amount
Temporarily restricted by fund house
Lumpsum amount
Temporarily restricted by fund house

DSP Credit Risk IDCW Monthly Payout Direct Plan

NAV
₹10.7885
+0.03%
(21 Sep)
AUM
194 Cr
TER
0.4%
Risk
Moderately High Risk
Rating
Insights
Total Expense Ratio (TER) is in the bottom 25% of comparable funds
Net Asset Value (NAV) is above its 200 days moving average
In beta. Send feedback here.
Compare with other fund
1Y
+7.8%
+7.5%
+7.5%
+7.5%
+7.5%
+6.6%
3Y
+7.6%
+11.6%
+11.6%
+11.6%
+11.6%
+9.4%
5Y
+5.4%
-0.8%
-0.8%
-0.8%
-0.8%
+4.5%
ALL
+5.5%
+0.5%
+0.5%
+1.9%
+1.9%
+5.7%
VOL
3.6%
9.1%
9.1%
8.8%
8.8%
-
TER
0.4%
0.8%
0.8%
0.8%
0.8%
-
AUM
₹194 Cr
₹414 Cr
₹414 Cr
₹414 Cr
₹414 Cr
-
INFO
1.55
0.05
0.05
0.21
0.21
-
Past performance
Past performance is no guarantee of future returns.
Had you invested
Over the last
1Y
3Y
ALL
Your returns would have been
DSP Credit Risk IDCW Monthly Payout (DP)
₹1,00,00,00,000
14.0%
Fixed deposit
₹40,00,00,000
6.0%
Bank savings
₹40,00,00,000
3.0%
See fund holdings as of 31st Aug
Top holdings
Treps / Reverse Repo Investments / Corporate Debt Repo
8.1%
JSW Steel Limited - NCD & Bonds - NCD & Bonds
8.0%
Kirloskar Ferrous Industries Ltd - NCD & Bonds - NCD & Bonds
7.9%
TATA Motors Limited - NCD & Bonds - NCD & Bonds
7.8%
Piramal Capital & Housing Finance Limited - NCD & Bonds - NCD & Bonds
7.8%
Godrej Industries Limited - NCD & Bonds - NCD & Bonds
7.7%
Nuvoco Vistas Corporation Limited - NCD & Bonds - NCD & Bonds
7.6%
Motilal Oswal Finvest Limited - Commercial Paper - Commercial Paper
5.5%
Piramal Pharma Ltd - NCD & Bonds - NCD & Bonds
5.5%
7.06% Govt Stock 2028
5.2%
Other information
Minimum SIP
Restricted (AMC)
Minimum lumpsum
Restricted (AMC)
Additional lumpsum
Restricted (AMC)
Portfolio turnover
-
Lock-in period
-
Exit load
• 1% for redemption within 365 days
Fund objective
An Open ended income Scheme, seeking to generate returns commensurate with risk from a portfolio constituted of money market securities and/or debt securities.
Fund manager(s)
Laukik Bagwe
Vivek Ramakrishnan

FAQs